伽玛刀立体定向放射外科治疗神经纤维瘤病2型(NF2)相关脑膜瘤:系统综述与Meta分析
本系统综述与Meta分析检索截至2024年3月21日的文献,纳入4项研究共101例接受伽玛刀立体定向放射外科(GKRS)治疗的NF2相关脑膜瘤患者。3年总生存率100%,5年98%(95%CI:0.95-1.01),10年68%(95%CI:0.48-0.87);3年无进展生存率95%(95%CI:89-101%),5年93%(95%CI:86-99%),10年81%(95%CI:51-111%)。汇总放射性坏死率5%(95%CI:3-7%),总放射毒性率16%(95%CI:11-21%)。作者结论认为GKRS对这一困难患者群体显示高效且安全性良好,是有价值的治疗选择。
要点
- 纳入4项研究共101例NF2相关脑膜瘤患者,均接受伽玛刀立体定向放射外科治疗。
- 3年总生存率100%,5年98%(95%CI:0.95-1.01),10年68%(95%CI:0.48-0.87)。
- 汇总放射性坏死率5%(95%CI:3-7%),总放射毒性率16%(95%CI:11-21%)。
核心结论
- 作者结论认为GKRS对NF2相关脑膜瘤显示高效且安全性良好,为这一困难患者群体提供了有价值的治疗选择。
研究设计与样本
- 系统综述与Meta分析,遵循PRISMA声明,检索PubMed/Medline、Embase、Scopus和Web of Science至2024年3月21日。
- 最终纳入4项研究,共101例接受立体定向放射外科治疗的NF2相关脑膜瘤患者,所有研究均使用伽玛刀立体定向放射外科(GKRS)。
主要发现
- 总生存率在治疗后3年内维持100%,5年为98%(95%CI:0.95-1.01),10年为68%(95%CI:0.48-0.87)。
- 无进展生存率3年为95%(95%CI:89-101%),5年为93%(95%CI:86-99%),10年为81%(95%CI:51-111%)。
- 汇总放射性坏死率为5%(95%CI:3-7%),总放射毒性率为16%(95%CI:11-21%)。
- 局部肿瘤控制率在6个月时较高,12个月时为100%(95%CI:1.00-1.00)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Neurofibromatosis type 2 (NF2)-related schwannomatosis is a rare genetic disorder associated with meningiomas. Stereotactic radiosurgery (SRS) has emerged as a potential non-invasive method. This study aims to synthesize the available evidence on using SRS to treat these tumors. METHODS: PubMed/Medline, Embase, Scopus, and Web of Science were searched until March 21, 2024. This study was prepared by adhering to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA). RESULTS: Four studies were included comprising 101 patients with NF2-associated meningiomas treated with SRS. All included studies used gamma knife stereotactic radiosurgery (GKRS) as treatment modality. Overall survival rates remained high (100%) up to 3 years post-treatment, with slight declines at five years of 98% (95% CI: 0.95-1.01) and ten years of 68% (95% CI: 0.48-0.87). Progression-free survival rates were similarly favorable, with 95% (95% CI: 89-101%) at three years, 93% (95% CI: 86-99%) at five years, and 81% (95% CI: 51-111%) at ten years. The pooled radiation necrosis rate was 5% (95% CI: 3-7%), while the overall radiation toxicity rate was 16% (95% CI: 11-21%). Local tumor control rates were high at six months, and at 12 months, they were 100% (95% CI: 1.00-1.00). CONCLUSION: GKRS demonstrates high efficacy and a favorable safety profile for NF2-associated meningiomas, offering a valuable treatment option for this challenging patient population.
引用
- Habibi MA, Mirjani MS, Ahmadvand MH, et al. Gamma knife stereotactic radiosurgery for neurofibromatosis 2 (NF2)-associated meningiomas; a systematic review and meta-analysis. Acta Neurochir (Wien). 2025. PMID: 39907804. doi:10.1007/s00701-025-06436-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。